Interestingly, despite HER3 and Akt inhibitors showing little efficacy in HCC1599 monocultures as single agents or in combination, testing a low-dose combination of sapitinib and MK2206 in the HCC1599 VMT revealed synergistic anti-cancer effects. The gene discussed is ERBB3; the disease is cancer.